Covering more than 175,000sq m, the facility will employ 250 people and have an annual production capacity of 20 billion ...

CDMO giant Lonza unveiled plans to expand hard gelatin capsule production capacity at plants in India and China a week after ...

The company has expanded significantly over the ensuing decades and currently touts its role in “almost every aspect of solid dosage manufacturing,” from capsule production to manufacturing ...

(Reuters) - Swiss contract drug manufacturer Lonza announced on Thursday it plans to exit the capsules and health ingredients business. The Basel-based group will focus on its contract development ...

Lonza officials say they have expanded the company’s service offering for orally delivered biologic therapies to support the unique development and manufacturing needs of smart capsule companies.

The Industrial Technology Research Institute (ITRI) has partnered with microcontroller unit (MCU) manufacturer Generalplus to ...